UBM Medica Corporate Officers

Article

Henry ElkingtonCEO, UBM Medica Ltd, UKPatrick McAleenanCFO, UBM Medica Ltd, UKSally ShanklandCEO, UBM Medica USASteve ResnickVP, Finance Director, USAJulia MurphyVP, Director of Human Resources, USAPamela L. Moore, PhDEVP, Content & Strategy, USAMorgan KelseyVP, Technology, USA

Henry Elkington
CEO, UBM Medica Ltd, UK

Patrick McAleenan
CFO, UBM Medica Ltd, UK

Sally Shankland
CEO, UBM Medica USA

Steve Resnick
VP, Finance Director, USA

Julia Murphy
VP, Director of Human Resources, USA

Pamela L. Moore, PhD
EVP, Content & Strategy, USA

Morgan Kelsey
VP, Technology, USA

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Historical standards for H3 K27M-mutant diffuse midline glioma treatment may harm healthy central nervous system cells, according to Ashley L. Sumrall, MD.